LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
Lyell Immunopharma to Participate in BofA Securities Health Care Conference [Yahoo! Finance]
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024 [Yahoo! Finance]
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
Form 424B5 Lyell Immunopharma, Inc.
Form 10-Q Lyell Immunopharma, Inc. For: Mar 31
Form 8-K Lyell Immunopharma, Inc. For: May 06
Form EFFECT Lyell Immunopharma, Inc.
Form ARS Lyell Immunopharma, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.